Diffuse idiopathic skeletal hyperostosis associated with bexarotene - 14/09/11
Doi : 10.1016/j.jaad.2010.10.015
Courtney R. Schadt, MD a, c, ⁎ 
, John A. Zic, MD a, c, Howard A. Fuchs, MD b, c
, John A. Zic, MD a, c, Howard A. Fuchs, MD b, c a Division of Dermatology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
b Division of Rheumatology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
c Tennessee Valley Healthcare System, Department of Veterans Affairs Medical Center, Nashville, Tennessee
Reprint requests: Courtney R. Schadt, MD, Dermatology Division, Vanderbilt Health, One Hundred Oaks, 719 Thompson Lane, Suite 26300, Nashville, TN 37204| Funding sources: None. |
|
| Disclosure: Dr. John Zic received honoraria to speak on behalf of Eisai Pharmaceuticals more than 5 years ago. |
© 2010
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 65 - N° 4
P. 883-884 - octobre 2011 Retour au numéro
Article précédent
- A case of angiosarcoma arising on a closed shunt in a patient with chronic renal failure
- Fuminao Kamijo, Yukiko Kiniwa, Yasufumi Goto, Shiho Shirota, Aya Kobayashi, Asuka Tanaka, Masao Fukuzawa, Toshiaki Saida
- CD4/CD8 double-negative early-stage mycosis fungoides associated with primary cutaneous follicular center lymphoma
- Jeong Hee Cho-Vega, Jaime A. Tschen, Francisco Vega
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?